The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

The new policy withdraws the COVID-19 vaccine recommendation for most children and pregnant women made by earlier vaccination policy. Groups suing include the American Academy of Pediatrics, the ...

Six major medical groups, and a pregnant physician, are suing HHS Secretary Robert F. Kennedy Jr. over changes he made to ...

Kennedy Jr. appeared on the latest episode of Tucker Carlson’s podcast on Monday and it’s filled with the ramblings of a man ...

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease ...